(NYSE:CXW), BRENTWOOD, Tenn., Dec. 12, 2025 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (“CoreCivic” or the “Company”) announced today that CoreCivic's Board of Directors (the “Board”) has appointed Daren Swenson, who currently serves as CoreCivic's Senior Vice President and Chief Corrections Officer, to Executive Vice President and Chief Corrections and Reentry Officer (CCRO), effective January […]

This agreement expands RadioMedix's access to essential 228Th resources, strengthening the Company's 212Pb pipeline and generator platform for its long-term Targeted Alpha Therapy strategy HOUSTON, Dec. 12, 2025 (GLOBE NEWSWIRE) — RadioMedix, Inc., a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and cancer therapy, today announced that they have entered into

(NYSE:WHG),(NYSE:YLDW), DALLAS, Dec. 12, 2025 (GLOBE NEWSWIRE) — Westwood Holdings Group (NYSE: WHG), a leading boutique asset manager, today announced the launch of the Westwood Enhanced Income Opportunity ETF (NYSE: YLDW), the newest addition to the Westwood Enhanced Income Series(TM) ETFs, part of Westwood's growing ETF platform, which recently surpassed $200M in AUM. YLDW expands

(NASDAQ:MLTX),(NASDAQ:DXCM),(NASDAQ:SNPS), ATLANTA, Dec. 12, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: MoonLake Immunotherapeutics (MLTX) The shareholder class action lawsuit filed against MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) alleges that Defendants made materially false and/or

(NASDAQ:ALGS), SOUTH SAN FRANCISCO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company's Board of Directors granted non-qualified stock options to purchase an

Oppenheimer Holdings Inc. (NYSE: OPY) today announced that its Board of Directors has declared a special cash dividend on OPY Class A non-voting and Class B voting common stock of $1.00 per share, payable January 9, 2026, to shareholders of record as of the close of business on December 26, 2025. The aggregate payment will

Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and extract manufactured products, is pleased to announce that the results of its annual and special meeting of shareholders held on December 11, 2025 (the “Meeting”). https://mma.prnewswire.com/media/2843980/Decibel_Cannabis_Company_Inc__Decibel_Announces_Results_of_Annua.jpg Results of the Meeting Decibel's shareholders approved all matters submitted

PLACE welcomes industry leadersNikki Miller, Jamie Jatzlau, and Claire Dunham PLACE, the real estate industry's only integrated technology, business services, and consumer platform for top-performing teams, announced today the addition of three seasoned leaders to its executive ranks: Nikki Miller, formerly of Movoto; Jamie Jatzlau, most recently with Realtor.com and previously General Counsel for OpCity

A pair of Mount St. Mary's alumni have turned a campus-born idea into a patented product now sold on Amazon, marking a major milestone for the university's entrepreneurship program. Mount St. Mary's University alumni Thunlwyn Garcia, C'23, and Anthony Milazzo, C'24, have officially brought their patented innovation, Temperature Regulated Insoles, to the Amazon marketplace through

LightPath Technologies, Inc. (NASDAQ: LPTH) (“LightPath,” the “Company,” “we,” or “our”), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced the pricing of an underwritten public offering of 7,750,000 shares of its Class A common stock at a price to the public of $7.75 per share for